Who is sponsoring NCT02079090?

NCT02079090 is sponsored by University of British Columbia.

What drugs are being tested in NCT02079090?

Interventions in NCT02079090: Ketofol, Fentofol.

What condition does NCT02079090 study?

NCT02079090 studies Emergency Department Procedural Sedation, Fracture Reduction.

Is NCT02079090 still recruiting?

NCT02079090 is currently completed. Last updated 25 October 2017.

Last reviewed 2017-10-25 · How we verify

NCT02079090

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ketofol Versus Fentofol for Procedural Sedation of Children 3 to 17 Years Old: a Double-Blind Randomized Controlled Trial

Completed Phase 3 Last updated 25 October 2017

What this trial tests

Phase 3 trial testing Ketofol in Emergency Department Procedural Sedation in 30 participants. Completed in 1 June 2017.

Timeline

1 July 2014

Primary endpoint
1 June 2017

1 June 2017

Quick facts

Lead sponsor	University of British Columbia
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	30
Start date	1 July 2014
Primary completion	1 June 2017
Estimated completion	1 June 2017
Sites	1 location across Canada

Drugs / interventions tested

Ketofol — full drug profile →
Fentofol — full drug profile →

Conditions studied

Emergency Department Procedural Sedation — all drugs for Emergency Department Procedural Sedation →
Fracture Reduction — all drugs for Fracture Reduction →

Sponsor

University of British Columbia

Who can join

Adults 3 to 17, any sex, with Emergency Department Procedural Sedation or Fracture Reduction. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Duration of Sedation
Time frame: Less than 30 minutes
Duration of sedation is measured from time of administration of Propofol (time 0) to recovery being achieved.

Sponsor's own description

Sedation and pain medication is required when bone fractures need to be fixed in the emergency department (ED). Many drugs have been used safely as single agents or in combination for the sedation of children. These drugs include Propofol, Ketamine and Fentanyl. However each of these medications has side effects and drawbacks. The combination of Propofol and Fentanyl (Fentofol) has never been compared directly with the combination of Propofol and Ketamine (Ketofol) for painful procedures in the ED, and the goal of this study is to determine which combination works better. The primary outcome of this study is to determine which drug combination has a shorter time from onset of sedation to full recovery. The investigators hypothesize that Fentofol will have shorter sedation to recovery times.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ketofol

Trials testing the same drug.

NCT07401914 — Ketodex Versus Ketofol in Adolescent Gastrointestinal Endoscopy · not yet recruiting
NCT07273851 — Comparison of Propofol and Ketofol as Induction Agents for Electroconvulsive Therapy · NA · completed
NCT05786833 — Dexmedetomidine vs Ketofol on Delirium in Children Undergoing Congenital Inguinal Hernia Repair · NA · unknown
NCT05655754 — Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT · Phase 4 · recruiting
NCT02643979 — Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy · Phase 4 · terminated

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02079090 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 25 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02079090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing